StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
99
This year
4
Publishing Date
2023 - 08 - 09
2
2023 - 02 - 01
1
2023 - 01 - 19
1
2022 - 12 - 22
1
2022 - 12 - 21
1
2022 - 12 - 13
1
2022 - 12 - 12
1
2022 - 12 - 05
2
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 07
1
2022 - 10 - 25
1
2022 - 10 - 12
1
2022 - 10 - 05
1
2022 - 09 - 22
1
2022 - 09 - 07
1
2022 - 09 - 02
1
2022 - 08 - 31
1
2022 - 07 - 20
1
2022 - 06 - 06
2
2022 - 05 - 25
1
2022 - 05 - 19
1
2022 - 05 - 16
1
2022 - 04 - 27
1
2022 - 04 - 20
1
2022 - 03 - 14
1
2022 - 03 - 02
1
2022 - 03 - 01
1
2022 - 02 - 15
1
2022 - 02 - 14
1
2022 - 01 - 21
1
2022 - 01 - 14
1
2021 - 12 - 29
1
2021 - 12 - 10
1
2021 - 12 - 02
1
2021 - 11 - 23
1
2021 - 11 - 17
1
2021 - 11 - 11
1
2021 - 11 - 09
1
2021 - 11 - 01
1
2021 - 10 - 07
1
2021 - 09 - 24
1
2021 - 09 - 20
3
2021 - 09 - 19
1
2021 - 08 - 25
1
2021 - 08 - 05
1
2021 - 06 - 28
1
2021 - 06 - 24
1
2021 - 06 - 04
1
2021 - 06 - 01
1
2021 - 05 - 25
1
2021 - 04 - 20
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 03 - 10
1
2021 - 02 - 10
1
2021 - 02 - 04
1
2021 - 01 - 11
1
2021 - 01 - 04
1
Sector
Consumer services
1
Distribution services
1
Finance
9
Health services
2
Health technology
99
Manufacturing
1
Miscellaneous
1
Process industries
1
Professional, scientific, and technical services
1
Tags
Acquired
1
Acquisition
1
Advanced
1
Agreement
2
Alliances
4
America
1
Application
3
Approval
2
Artificial intelligence
1
Asco
2
Authorization
1
Biocapital
1
Biomarkers
2
Bioscience
3
Biotech-beach
12
Biotechnology
3
Breakthrough therapy
1
Cancer
32
Cancer drug
1
Care
2
Cel
1
Cell
4
Collaboration
5
Colorectal cancer
2
Conference
11
Designation
2
Diagnostic
3
Drug
5
Earnings
2
Events
2
Fda
5
Financial
7
Financial results
5
Food
3
Global
3
Grant
6
Health
3
Krasg12
12
Lung
11
Lung cancer
7
N/a
65
Nasdaq
5
New drug
2
Offering
4
Pharm-country
2
Phase 1
2
Positive
4
Report
8
Research
7
Results
25
Sapphire
2
Study
4
System
2
Test
3
Therapeutics
49
Therapy
4
Treatment
9
Tumors
4
Update
3
World
2
Entities
Abbvie inc.
156
Abeona therapeutics inc.
116
Adc therapeutics sa
145
Addex therapeutics ltd
101
Akebia therapeutics, inc.
116
Akero therapeutics, inc.
104
Aldeyra therapeutics, inc.
123
Allogene therapeutics, inc.
177
Alphabet inc.
196
Alterity therapeutics limited
106
Amarin corporation plc
137
Amgen inc.
137
Aquestive therapeutics, inc.
147
Astrazeneca plc
118
Autolus therapeutics plc
105
Axsome therapeutics, inc.
116
Biogen inc.
104
Bioxcel therapeutics, inc.
168
Brainstorm cell therapeutics inc.
131
Bristol-myers squibb company
131
Calliditas therapeutics ab
141
Denali therapeutics inc.
104
Eli lilly and company
284
Fate therapeutics, inc.
256
Fulcrum therapeutics, inc.
134
G1 therapeutics, inc.
136
Gilead sciences, inc.
107
Glaxosmithkline plc
151
Horizon therapeutics public limited company
146
Hoth therapeutics, inc.
109
Intellia therapeutics, inc.
112
Johnson & johnson
525
Karyopharm therapeutics inc.
166
Lineage cell therapeutics, inc.
109
Medicenna therapeutics corp.
108
Morgan stanley
208
Morphosys ag
189
Nektar therapeutics
369
Novartis ag
226
Nurix therapeutics, inc.
147
Oncocyte corporation
181
Onconova therapeutics, inc.
114
Outlook therapeutics, inc.
147
Plus therapeutics, inc.
124
Poseida therapeutics, inc.
110
Ptc therapeutics, inc.
269
Relief therapeutics holding sa
109
Sanofi
710
Sarepta therapeutics, inc.
164
Seres therapeutics, inc.
116
Sorrento therapeutics, inc.
229
Spero therapeutics, inc.
121
Tg therapeutics, inc.
148
Therapeuticsmd, inc.
193
Travere therapeutics inc.
120
United therapeutics corporation
142
Vaxart, inc.
184
Vistagen therapeutics, inc.
116
Vyne therapeutics inc.
172
Y-mabs therapeutics, inc.
178
Symbols
A
1
AADI
1
ABBV
1
ABSI
1
AGEN
1
AMGN
3
AMRX
1
BMY
10
BNTX
1
BPMC
2
CORT
1
ETTX
1
EVR
1
FCFS
1
GILD
1
GLAXF
1
GMAB
1
GNMSF
1
GSK
1
INCY
3
JNJ
2
KRTX
4
KURA
1
LLY
4
MACK
1
MCK
1
MRK
1
MRNA
1
MRTX
99
MS
6
NEO
1
NVCR
2
ONCY
2
ORIC
1
OSH
1
PHAT
1
PPG
1
PRPL
1
QGEN
2
QURE
1
ROL
1
RVMD
1
RYZB
1
SEER
1
SGEN
2
SNY
3
SNYNF
2
TPTX
1
VSTM
1
XYF
2
ZLAB
5
Exchanges
Nasdaq
99
Nyse
24
Crawled Date
2023 - 08 - 09
2
2023 - 02 - 03
1
2023 - 02 - 01
1
2023 - 01 - 19
1
2022 - 12 - 22
1
2022 - 12 - 21
1
2022 - 12 - 13
2
2022 - 12 - 06
2
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 07
1
2022 - 10 - 25
1
2022 - 10 - 12
1
2022 - 10 - 05
1
2022 - 09 - 22
1
2022 - 09 - 07
1
2022 - 09 - 02
1
2022 - 08 - 31
1
2022 - 07 - 20
1
2022 - 06 - 06
2
2022 - 05 - 25
1
2022 - 05 - 19
1
2022 - 05 - 16
1
2022 - 04 - 27
1
2022 - 04 - 20
1
2022 - 03 - 14
1
2022 - 03 - 02
1
2022 - 03 - 01
1
2022 - 02 - 15
1
2022 - 02 - 14
1
2022 - 01 - 21
1
2022 - 01 - 14
1
2021 - 12 - 30
1
2021 - 12 - 10
1
2021 - 12 - 02
1
2021 - 11 - 23
1
2021 - 11 - 17
1
2021 - 11 - 11
1
2021 - 11 - 09
1
2021 - 11 - 01
1
2021 - 10 - 07
1
2021 - 09 - 25
1
2021 - 09 - 20
3
2021 - 09 - 19
1
2021 - 08 - 25
1
2021 - 08 - 05
1
2021 - 06 - 28
1
2021 - 06 - 24
1
2021 - 06 - 04
1
2021 - 06 - 01
1
2021 - 05 - 26
1
2021 - 04 - 20
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 03 - 10
1
2021 - 02 - 10
1
2021 - 02 - 05
1
2021 - 01 - 11
1
2021 - 01 - 04
1
Crawled Time
00:00
4
00:20
1
01:00
2
04:20
1
05:00
1
06:00
1
09:00
1
10:00
1
11:00
2
12:00
6
12:15
1
12:30
1
13:00
7
13:15
1
13:20
1
13:30
1
14:00
1
14:15
2
14:30
2
15:00
1
15:30
1
16:00
1
16:20
1
17:00
2
18:00
1
19:00
3
20:00
12
20:20
1
21:00
18
22:00
11
22:04
1
23:00
8
23:07
1
Source
www.biospace.com
34
www.globenewswire.com
8
www.prnewswire.com
57
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
entities :
Mirati therapeutics, inc.
save search
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
Published:
2024-02-02
(Crawled : 14:30)
- biospace.com/
RYZB
|
$62.49
0.03%
280K
|
|
0.64%
|
O:
0.03%
H:
0.11%
C:
0.0%
XYF
|
News
|
$3.882
-0.46%
0.0%
340
|
Finance
|
-0.26%
|
O:
1.04%
H:
1.79%
C:
-1.23%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
0.97%
|
O:
1.23%
H:
1.5%
C:
-1.14%
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
5.24%
|
O:
0.06%
H:
0.0%
C:
0.0%
financial
results
Corcept Appoints Roberto Vieira as President, Oncology
Published:
2024-01-29
(Crawled : 13:00)
- globenewswire.com
CORT
|
News
|
$23.0
3.14%
3.04%
1.9M
|
Health Technology
|
2.95%
|
O:
0.6%
H:
2.48%
C:
2.48%
Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio
Published:
2024-01-23
(Crawled : 14:30)
- biospace.com/
MS
|
News
0 d
|
$93.76
1.81%
0.12%
6.4M
|
Finance
|
7.42%
|
O:
-0.07%
H:
1.38%
C:
1.25%
EVR
|
$196.1
2.09%
0.0%
510K
|
Finance
|
9.59%
|
O:
0.35%
H:
0.29%
C:
-0.26%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-0.87%
|
O:
0.22%
H:
1.49%
C:
0.89%
acquisition
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Published:
2024-01-10
(Crawled : 13:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
-0.31%
|
O:
0.02%
H:
0.17%
C:
-0.19%
krasg12
lung
cancer
cell
treatment
advanced
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Published:
2023-11-10
(Crawled : 12:30)
- prnewswire.com
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-2.52%
|
O:
0.4%
H:
0.18%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
4.61%
|
O:
-0.11%
H:
0.0%
C:
0.0%
krasg12
lung
chmp
positive
cancer
cell
treatment
therapeutics
Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
Published:
2023-11-07
(Crawled : 21:00)
- globenewswire.com
GNMSF
|
News
|
$289.67
3.83%
5.3K
|
Health Technology
|
-0.37%
|
O:
6.62%
H:
2.29%
C:
-0.06%
ZLAB
|
$15.13
0.93%
0.93%
470K
|
Health Technology
|
-47.05%
|
O:
8.3%
H:
0.02%
C:
-2.12%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
6.91%
|
O:
0.49%
H:
0.0%
C:
-0.57%
NVCR
|
$12.055
1.9%
1.87%
750K
|
Health Technology
|
-8.08%
|
O:
0.7%
H:
0.0%
C:
-6.94%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
4.89%
|
O:
0.29%
H:
0.21%
C:
-0.48%
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
83.73%
|
O:
0.27%
H:
0.14%
C:
-3.34%
GMAB
|
News
|
$28.54
-1.48%
-1.51%
560K
|
Health Technology
|
-1.86%
|
O:
7.35%
H:
0.44%
C:
-2.18%
results
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
Published:
2023-11-06
(Crawled : 15:00)
- biospace.com/
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-6.97%
|
O:
0.61%
H:
0.77%
C:
-0.66%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
5.6%
|
O:
0.75%
H:
0.59%
C:
0.27%
therapeutics
financial
results
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
Published:
2023-11-02
(Crawled : 12:00)
- globenewswire.com
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-4.17%
|
O:
-0.9%
H:
1.08%
C:
0.61%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
5.41%
|
O:
0.2%
H:
0.43%
C:
-0.38%
KURA
|
News
|
$18.74
3.02%
2.93%
1M
|
Health Technology
|
127.66%
|
O:
0.13%
H:
6.0%
C:
5.25%
ko-2806
collaboration
therapeutics
agreement
Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes
Published:
2023-10-31
(Crawled : 06:00)
- biospace.com/
MS
|
News
0 d
|
$93.76
1.81%
0.12%
6.4M
|
Finance
|
31.33%
|
O:
0.83%
H:
0.0%
C:
0.0%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-4.12%
|
O:
0.25%
H:
0.54%
C:
0.29%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
6.12%
|
O:
0.46%
H:
0.0%
C:
0.0%
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
Published:
2023-10-26
(Crawled : 13:00)
- biospace.com/
XYF
|
News
|
$3.882
-0.46%
0.0%
340
|
Finance
|
-1.79%
|
O:
-3.19%
H:
4.87%
C:
4.87%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-13.2%
|
O:
-4.68%
H:
2.46%
C:
-1.83%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
6.54%
|
O:
0.16%
H:
0.47%
C:
0.2%
financial
results
Mirati Presents Late-Breaking Results Evaluating the Combination of Adagrasib and Pembrolizumab in First-Line Non-Small Cell Lung Cancer (NSCLC)
Published:
2023-10-17
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
3.98%
|
O:
-0.04%
H:
0.35%
C:
-0.53%
lung
cancer
cell
results
Pancreatic Cancer Battle Boosted by $200M VC Firm
Published:
2023-09-19
(Crawled : 17:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-46.08%
|
O:
-1.47%
H:
4.98%
C:
3.98%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
84.91%
|
O:
-0.13%
H:
2.0%
C:
1.83%
MACK
4
|
$14.73
0.0%
80K
|
Health Technology
|
20.34%
|
O:
-0.41%
H:
0.9%
C:
0.74%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
|
-12.75%
|
O:
0.03%
H:
2.18%
C:
1.8%
BNTX
|
News
|
$88.53
0.59%
0.59%
360K
|
Health Technology
|
-19.29%
|
O:
-0.01%
H:
1.99%
C:
1.28%
cancer
pancreatic
Mirati Presents Two-Year Follow-Up Data from KRYSTAL-1 Study Demonstrating Durable Response and Long-Term Overall Survival at 2023 World Conference on Lung Cancer
Published:
2023-09-10
(Crawled : 04:20)
- prnewswire.com
MS
|
News
0 d
|
$93.76
1.81%
0.12%
6.4M
|
Finance
|
Email alert
Add to watchlist
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
lung
conference
world
cancer
response
study
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Published:
2023-09-05
(Crawled : 20:00)
- prnewswire.com
MS
|
News
0 d
|
$93.76
1.81%
0.12%
6.4M
|
Finance
|
7.27%
|
O:
-1.87%
H:
0.0%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
64.44%
|
O:
0.36%
H:
0.86%
C:
-1.17%
nasdaq
grant
therapeutics
Mirati Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
Published:
2023-08-29
(Crawled : 20:00)
- prnewswire.com
MS
|
News
0 d
|
$93.76
1.81%
0.12%
6.4M
|
Finance
|
9.0%
|
O:
1.44%
H:
0.0%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
61.37%
|
O:
0.69%
H:
1.04%
C:
1.01%
conference
global
therapeutics
Mirati To Present Pooled Clinical Data from Adagrasib's KRYSTAL-1 Study Demonstrating Overall Survival Results at Two-Years of Follow-Up at 2023 World Conference on Lung Cancer
Published:
2023-08-21
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
55.36%
|
O:
0.5%
H:
1.29%
C:
-1.02%
lung
conference
world
cancer
results
study
Mirati Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published:
2023-08-11
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
offering
therapeutics
Mirati Therapeutics Announces Pricing of Upsized Public Offering - August 09, 2023
Published:
2023-08-09
(Crawled : 11:00)
- biospace.com/
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
109.7%
|
O:
23.42%
H:
8.46%
C:
6.87%
offering
therapeutics
Mirati Therapeutics Announces Pricing of Upsized Public Offering
Published:
2023-08-09
(Crawled : 05:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
109.7%
|
O:
23.42%
H:
8.46%
C:
6.87%
offering
therapeutics
Mirati Therapeutics® to Report Second Quarter 2023 Financial Results and Recent Corporate Updates on August 8, 2023
Published:
2023-07-25
(Crawled : 21:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
92.47%
|
O:
0.29%
H:
0.0%
C:
-2.19%
therapeutics
report
financial
results
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.